{"id":2205,"date":"2018-06-14T13:52:00","date_gmt":"2018-06-14T13:52:00","guid":{"rendered":"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/?p=2205"},"modified":"2023-11-21T16:11:51","modified_gmt":"2023-11-21T16:11:51","slug":"dissecting-ngly1-deficiency-an-interview-with-ulla-gerling-driessen-will-mueller","status":"publish","type":"post","link":"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/2018\/06\/dissecting-ngly1-deficiency-an-interview-with-ulla-gerling-driessen-will-mueller\/","title":{"rendered":"Dissecting NGLY1 deficiency &#8211; An interview with Ulla Gerling-Driessen &amp; Will Mueller"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/research\/dissecting-ngly1-deficiency\/\">Project &#8211; Dissecting NGLY1&nbsp;Deficiency<\/a><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><em>The&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/gracescience.org\/\" target=\"_blank\">Grace Science Foundation<\/a>&nbsp;(GSF) was established to find, recruit, and fund a diverse team of researches across the globe to study a condition known as N -Glycanase 1 (NGLY1) deficiency. This is a rare disease that currently affects 47 patients worldwide. GSF has recruited five groups from EMBL and Stanford to be part of the worldwide team of researchers studying&nbsp;<a href=\"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/research\/dissecting-ngly1-deficiency\/\">NGLY1 deficiency<\/a>&nbsp;with expertise in various aspects of biology. Scientists from the Steinmetz Group at EMBL and the Bertozzi Group at Stanford are part of the research team. We caught up with two postdocs, Will Mueller (EMBL) and Ulla Gerling-Driessen (Stanford), to learn about the NGLY1 project, get their tips on effective collaboration, and what lessons they\u2019ll take with them in the next phase of their careers.<\/em><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Tell us about the project that you&#8217;re both working on.<\/strong><\/h3>\n\n\n\n<p>Will: NGLY1 deficiency is caused by mutations in the NGLY1 gene that result in a loss of function. Although the function of the gene was known, it wasn\u2019t clear how mutations in this gene could cause disease. Our lab was involved in multiomic profiling to look at cell-wide changes in the gene-to-protein pipeline and see what happens when you lose NGLY1. The Bertozzi Group looked into some of the hits we found, and identified one of the targets of NGLY1.<\/p>\n\n\n\n<p>Ulla: We were able to link the activity of NGLY1 to the transcription factor Nrf1. It turns out that NRF1 is activated via a very unconventional pathway \u2013 the ERAD pathway \u2013 in which NGLY1 is a key player. The main function of Nrf1 is maintenance of the proteasome, which is particularly important under conditions of cellular stress.<\/p>\n\n\n\n<p>The functions of Nrf1 are very diverse: it\u2019s involved in the cell\u2019s antioxidant response, in proteasome function, embryonic development and particularly neuron development. By establishing this causal relationship, we were able to explain some of the diverse symptoms of NGLY1 deficiency, which until then were not well understood.<\/p>\n\n\n\n<blockquote class=\"vf-blockquote | vf-u-margin__bottom--600 vf-u-margin__top--600\">\n  <div>\n    <div>\n      It\u2019s been an incredibly wonderful thing to say, \u201cThis is cool, but I don\u2019t know what it means. I could Google it, or I could send an email to this team of people and get some wonderful suggestions and responses.\u201d\r\n    <\/div>\n    \n      <\/div>\n<\/blockquote>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>How has this project benefitted from a collaborative approach?<\/strong><\/h3>\n\n\n\n<p>Ulla: It\u2019s important to say that it was not just us and EMBL. There\u2019s a team and a lot of people involved who all have the same aim of finding a treatment and understanding the disease. They all look at it from a different angle and from that we can we can build an overall understanding of the disease.<\/p>\n\n\n\n<p>Will: The expertise of Ulla and the Bertozzi Group allowed us to work together to draw better conclusions from our data. Without Ulla\u2019s work, the relevance and context of the gene profile we saw wouldn\u2019t have made much sense. Now the Bertozzi Group is following up on Nrf1 as a potential therapeutic target, not only for NGLY1 deficiency but also for other diseases.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong><strong>How do you think you have personally benefitted from this project?<\/strong><\/strong><\/h3>\n\n\n\n<p>Will: The contacts that we\u2019ve made are great and have made my work easier. It\u2019s been an incredibly wonderful thing to say, \u201cThis is cool, but I don\u2019t know what it means. I could Google it, or I could send an email to this team of people and get some wonderful suggestions and responses.\u201d So it\u2019s the realest \u2018two minds are better than one\u2019 experience that I\u2019ve ever had.<\/p>\n\n\n\n<p>Ulla: I met a great person! (She means Will). It\u2019s also given me an introduction to EMBL, which is somewhere I would be excited about carrying on my research in the future. I think the collaborative environment at EMBL reflects the benefits that we also experience with the NGLY1 project.<\/p>\n\n\n\n<blockquote class=\"vf-blockquote | vf-u-margin__bottom--600 vf-u-margin__top--600\">\n  <div>\n    <div>\n      &#8220;Nobody can be an expert in everything. Combining expertise in different areas is the best way to answer a big question or work on a challenging project.&#8221;    <\/div>\n    \n      <\/div>\n<\/blockquote>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>The Life Science Alliance offers joint postdoc positions between EMBL and Stanford. Why should other researchers consider taking on a collaborative project?<\/strong><\/h3>\n\n\n\n<p>Will: Because you never know where it\u2019s going to lead or what possibilities the other person\u2019s expertise will open up \u2013 either for the project or yourself.<\/p>\n\n\n\n<p>Ulla: Nobody can be an expert in everything. Combining expertise in different areas is the best way to answer a big question or work on a challenging project.<\/p>\n\n\n\n<p>Read more about research in the&nbsp;<a href=\"https:\/\/www.embl.org\/groups\/steinmetz\/\" target=\"_blank\" rel=\"noreferrer noopener\">Steinmetz Group<\/a>&nbsp;at EMBL or the&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/bertozzigroup.stanford.edu\/\" target=\"_blank\">Bertozzi Group<\/a>&nbsp;at Stanford.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We caught up with two of our postdocs from the Bertozzi and Steinmetz labs who are working on the project dissecting NGLY1 deficiency. They talk to us about their work on the project, tips for collaboration and how it will play a role in their future careers.<\/p>\n","protected":false},"author":1,"featured_media":2217,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"embl_taxonomy":[],"class_list":["post-2205","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"acf":[],"embl_taxonomy_terms":[],"featured_image_src":"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/wp-content\/uploads\/2023\/11\/WillMueller_UllaGerling-Driessen.jpeg","_links":{"self":[{"href":"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/wp-json\/wp\/v2\/posts\/2205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/wp-json\/wp\/v2\/comments?post=2205"}],"version-history":[{"count":16,"href":"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/wp-json\/wp\/v2\/posts\/2205\/revisions"}],"predecessor-version":[{"id":2309,"href":"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/wp-json\/wp\/v2\/posts\/2205\/revisions\/2309"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/wp-json\/wp\/v2\/media\/2217"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/wp-json\/wp\/v2\/media?parent=2205"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/wp-json\/wp\/v2\/categories?post=2205"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/wp-json\/wp\/v2\/tags?post=2205"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/about\/info\/life-science-alliance\/wp-json\/wp\/v2\/embl_taxonomy?post=2205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}